Analystreport

Immune Design Corp (NASDAQ: IMDZ) had its price target lowered by analysts at HC Wainwright to $7.75. They now have a "buy" rating on the stock.

IMMUNE DESIGN CORP COMMON STOCK  (IMDZ) 
Last immune design corp common stock earnings: 11/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.immunedesign.com/investor-relations